Green Alpha Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,720
Closed -$424K 117
2024
Q4
$424K Sell
3,720
-117
-3% -$13.4K 0.34% 100
2024
Q3
$456K Sell
3,837
-159
-4% -$14.6K 0.36% 93
2024
Q2
$321K Sell
3,996
-1,823
-31% -$167K 0.26% 106
2024
Q1
$537K Buy
5,819
+666
+13% +$63.9K 0.39% 94
2023
Q4
$544K Sell
5,153
-56
-1% -$5.64K 0.39% 103
2023
Q3
$566K Buy
5,209
+2,519
+94% +$279K 0.43% 87
2023
Q2
$290K Buy
2,690
+92
+4% +$10.3K 0.19% 128
2023
Q1
$324K Sell
2,598
-808
-24% -$111K 0.23% 125
2022
Q4
$512K Buy
3,406
+97
+3% +$14.9K 0.43% 94
2022
Q3
$446K Buy
3,309
+454
+16% +$69.4K 0.38% 114
2022
Q2
$426K Sell
2,855
-1,151
-29% -$176K 0.1% 133
2022
Q1
$683K Buy
4,006
+436
+12% +$73.3K 0.46% 89
2021
Q4
$920K Buy
3,570
+68
+2% +$18.6K 0.62% 78
2021
Q3
$956K Buy
3,502
+28
+0.8% +$8.9K 0.66% 74
2021
Q2
$778K Buy
+3,474
New +$655K 0.53% 96

Other funds holding BNTX

Green Alpha Advisors's BNTX Position: Q1 2025 in Review

Green Alpha Advisors sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 3,720 shares — an estimated $424K sold.

Green Alpha Advisors first reported a position in BNTX in Q2 2021 and held it in 15 quarters. The position peaked at $956K in Q3 2021. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Green Alpha Advisors reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Green Alpha Advisors sold 3,720 BioNTech shares in Q1 2025, an estimated $424K.
  • Green Alpha Advisors first reported a position in BioNTech in Q2 2021 and held it in 15 quarters.
  • Green Alpha Advisors's BioNTech position peaked at $956K in Q3 2021.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Green Alpha Advisors's 13F filing for Q1 2025, filed 9 Apr 2025.